Altamira Therapeutics Ltd.

The current price of CYTO is 1.50 USD — it has increased by 1.35% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Altamira Therapeutics Ltd. stocks are traded under the ticker CYTO.

Altamira Therapeutics Ltd. is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.

CYTO stock is 6.94% volatile and has beta coefficient of 1.39. Check out the list of the most volatile stocks — is Altamira Therapeutics Ltd. there?

CYTO earnings for the last quarter are −244.84 USD whereas the estimation was −510.79 USD which accounts for 52.07% surprise. Estimated earnings for the next quarter are −438.94 USD. See more details about Altamira Therapeutics Ltd. earnings.

Yes, you can track Altamira Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.

Today Altamira Therapeutics Ltd. has the market capitalization of ‪2.37 M‬, it has decreased by 6.34% over the last week.

No, CYTO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, CYTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Altamira Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.

CYTO reached its all-time high on Jan 6, 2016 with the price of 3184.00 USD, and its all-time low was 1.61 USD and was reached on Feb 7, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 12.00 employees. See our rating of the largest employees — is Altamira Therapeutics Ltd. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Altamira Therapeutics Ltd. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Altamira Therapeutics Ltd. stock shows the sell signal. See more of Altamira Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.